Alkeus Pharmaceuticals (United States)
- Research works
- 26 ▲ 209% vs 2013–17
- Citations
- 196 7.5 per fractional work
- Top-10% rate
- 2.3% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Alkeus Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.
Which keywords describe research at Alkeus Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Diagnosis, Management, Global Burden, COPD, spirometry, Genetic Variants, Clinical Genomics and Sequence Interpretation.
- phosphate
- Second Primary Neoplasms
- Multiple Primary Cancers
- FGF23
- Clinical Genomics
- Genetic Variants
- Inflammation
- Global Burden
- Management
- Diagnosis
- COPD
- spirometry
- Epidemiology
- Quality of Life
- Sequence Interpretation
- Interactional Expertise
- Oxidative Stress
- Tacit Knowledge
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 18 words, with their numbers
- Diagnosis2▲ 9.5×4 topics
- Management2▲ 12×3 topics
- COPD2▲ 124×1 topic
- Global Burden2▲ 15×2 topics
- spirometry2▲ 124×1 topic
- Inflammation2▲ 2.7×8 topics
- Epidemiology1◆ 1.13×10 topics
- Genetic Variants1▲ 21×3 topics
- Quality of Life1▲ 3.5×7 topics
- Clinical Genomics1▲ 171×1 topic
- Sequence Interpretation1▲ 171×1 topic
- FGF231▲ 104×1 topic
- Interactional Expertise1▲ 230×1 topic
- Multiple Primary Cancers1▲ 178×1 topic
- Oxidative Stress1▲ 2.1×5 topics
- Second Primary Neoplasms1▲ 178×1 topic
- Tacit Knowledge1▲ 64×1 topic
- phosphate1▲ 104×1 topic
Which research topics does Alkeus Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Genomics and Rare Diseases, Parathyroid Disorders and Treatments, Pharmaceutical studies and practices and BRCA gene mutations in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genomics and Rare Diseases Genetics 1 works
- 2 Parathyroid Disorders and Treatments Nephrology 1 works
- 3 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 4 BRCA gene mutations in cancer Genetics 0 works
- 5 CCD and CMOS Imaging Sensors Electrical and Electronic Engineering 0 works
- 6 Digital Image Processing Techniques Computer Vision and Pattern Recognition 0 works
- 7 Biosimilars and Bioanalytical Methods Immunology 0 works
- 8 Educational Methods and Media Use Information Systems 0 works
- 9 Groundwater flow and contamination studies Environmental Engineering 0 works
- 10 Digestive system and related health Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alkeus Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 209% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.